Ohio DOT Small City Program Grants
Sector: Road • Location: Ohio, United States
Source: AASHTO Journal
The Ohio Department of Transportation issued $12.7 million in grants to eight communities through its Small City Program to support critical road infrastructure improvements that enhance safety, accessibility, and economic development in cities with populations between 5,000 and 24,999 not part of a Metropolitan Planning Organization.
Project Information FAQ
Project Information
Want to explore the full details? View the full report
Participants
Sponsoring Agency | Obfuscated Data |
Company | Obfuscated Data |
Status
Original status | awarded |
Taiyo status | Obfuscated Data |
Taiyo last update | 00-00-0000 |
Available timestamps | 00-00-0000 |
Available timestamp type | Obfuscated Data |
Contact
Contact name | Obfuscated Data |
Phone | 0000000000 |
ObfuscatedData@email.com | |
Address | Obfuscated Data, Obfuscated data, obfuscated data, Obfuscated data |
Description
Description | The Ohio Department of Transportation issued $12.7 million in grants to eight communities through its Small City Program to support critical road infrastructure improvements that enhance safety, accessibility, and economic development in cities with populations between 5,000 and 24,999 not part of a Metropolitan Planning Organization. |
Original sub-sector | Obfuscated |
Original Currency | USD |
Original budget | 000000000000000 |
Procurement method | Obfuscated Data |
Budget | 000000000000000 |
Location
Region | Obfuscated |
Country | Obfuscated |
State | Obfuscated Data |
County | Obfuscated |
Location | Obfuscated Data, Obfuscated data, obfuscated data, Obfuscated data |
Source
Source reliability | High |
Data quality score | 100% |
Source | Obfuscated Data |
URL | obfuscated_data,obfuscateddata.com |
More Details
Project Type | Obfuscated Data |
Article Published Date | Obfuscated Data |
More Road projects in United States
- Engineering, Procurement, and Construction of Third Bosphorus Bridge
- Morphotek’s New Biologics Production Facility
- LabCentral 238, Cambridge, Massachusetts, USA
- Kite Pharma’s Viral Vector Manufacturing Facility, California, US
- Eli Lilly’s Parenteral Product and Device Manufacturing Facility, Concord, North Carolina
- Amgen’s Drug Substance Manufacturing Plant, Wake County, North Carolina
- Vertex Pharmaceuticals’ Boston Campus
- Roche Diagnostics PCR Diagnostic Kits
